QCR7 (Ubiquinol-cytochrome c reductase complex subunit 7) is a nuclear-encoded subunit of mitochondrial complex III, essential for electron transfer and proton pumping across the inner mitochondrial membrane . Antibodies against QCR7 are used to detect this protein in various experimental models, including yeast, plants (e.g., Arabidopsis thaliana), and humans .
Immunogen: Synthetic peptide (15 aa from the C-terminal) of Arabidopsis QCR7 (AT4G32470) .
Applications:
Target: UQCRC2 (core protein 2 of complex III), a partner subunit of QCR7 in humans .
Applications:
| Application | Dilution Range |
|---|---|
| WB | 1:2000–1:12,000 |
| IHC | 1:200–1:1200 |
| IF/ICC | 1:50–1:500 |
| IP | 0.5–4.0 µg per 1–3 mg lysate |
The C-terminal region of cytochrome b (Cytb) interacts with QCR7 during complex III assembly in yeast. Truncation of Cytb’s C-terminus disrupts assembly-feedback regulation, impairing respiratory function .
Key Interaction: QCR7 binds early to Cytb during assembly, facilitating proton channel formation .
In Candida albicans, QCR7 knockout (qcr7Δ/Δ) strains exhibit:
Reduced Virulence: Attenuated kidney colonization and survival in mouse models .
Mitochondrial Dysfunction: Lower ATP levels, elevated ROS, and disrupted membrane potential .
Carbon Source Utilization Defects: Impaired growth on GlcNAc, lactate, and amino acids .
Biofilm/Hyphal Deficits: Compromised surface adhesion and hyphal maintenance .
Overexpression of cell-surface genes (HWP1, SAP6) restores virulence and carbon utilization in qcr7Δ/Δ mutants, linking mitochondrial function to host-pathogen interactions .
QCR7-2 is a subunit of mitochondrial ubiquinol-cytochrome c oxidoreductase (Complex III) in Arabidopsis thaliana. It plays a critical role in the electron transport chain, accepting electrons from quinol and transferring them to cytochrome c. In Arabidopsis mitochondria, Complex III contains 10 subunits with QCR7-2 being encoded by the AT5G25450 gene, while a similar protein QCR7-1 is encoded by AT4G32470 . Studies in fungi (Candida albicans) have demonstrated that QCR7 is essential for mitochondrial function, with knockout strains showing significant mitochondrial dysfunction . The protein's central role in electron transport makes it essential for proper mitochondrial respiratory function and cellular energy production in eukaryotic organisms.
For maximum stability and performance, QCR7-2 antibody should be stored at -20°C or -80°C immediately upon receipt . Repeated freeze-thaw cycles should be strictly avoided as they can significantly degrade antibody quality and experimental reproducibility. The antibody is typically supplied in a protective storage buffer containing 0.03% Proclin 300 as a preservative, 50% glycerol for stability, and 0.01M PBS at pH 7.4 . For experiments requiring multiple uses, it is recommended to prepare small single-use aliquots upon receipt to minimize freeze-thaw cycles. When handling the antibody, maintain aseptic conditions and use appropriate laboratory precautions to prevent contamination.
QCR7-2 antibody has been validated primarily for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . When used for Western blotting, the recommended dilution range is typically 1:1000-1:2000, though optimal concentration should be empirically determined for each experimental system . The antibody has been confirmed to react specifically with Arabidopsis thaliana samples and is designed to detect the native QCR7-2 protein at approximately 14-15 kDa . It's important to note that while some researchers may adapt this antibody for other applications such as immunohistochemistry or immunofluorescence, such uses would require extensive validation before yielding reliable results.
Optimizing Western blot protocols for QCR7-2 antibody requires careful attention to several key parameters. First, mitochondrial proteins should be extracted using specialized mitochondrial isolation buffers containing appropriate protease inhibitors to preserve QCR7-2 integrity. For SDS-PAGE, 12-15% gels are recommended to optimally resolve the 14-15 kDa QCR7-2 protein . After transfer to PVDF or nitrocellulose membranes, blocking should be performed with 5% non-fat milk or BSA in TBST for at least 1 hour at room temperature. For primary antibody incubation, use QCR7-2 antibody at 1:1000-1:2000 dilution in blocking buffer overnight at 4°C . After washing with TBST (3-5 times, 5 minutes each), incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000) for 1 hour at room temperature. For detection, enhanced chemiluminescence systems offer optimal sensitivity for visualizing the target protein.
To rigorously validate QCR7-2 antibody specificity, multiple complementary approaches should be employed. First, conduct Western blot analysis comparing wild-type Arabidopsis tissue with QCR7-2 knockout tissue to confirm absence of signal in the knockout. Second, perform peptide competition assays by pre-incubating the antibody with excess immunizing peptide before application, which should abolish specific signals. Third, validate expected molecular weight (14-15 kDa) and subcellular localization (mitochondria) in fractionation experiments . Fourth, conduct cross-reactivity testing against the homologous QCR7-1 protein to ensure specificity. Fifth, employ immunoprecipitation followed by mass spectrometry to confirm the antibody captures the intended target. Finally, if available, compare results with those obtained using alternative QCR7-2 antibodies raised against different epitopes to establish consistent detection patterns.
QCR7-2 antibody serves as a valuable tool for investigating mitochondrial Complex III assembly through multiple experimental approaches. Blue native polyacrylamide gel electrophoresis (BN-PAGE) combined with Western blotting using QCR7-2 antibody can visualize intact Complex III and assembly intermediates. To implement this approach, solubilize mitochondrial membranes with mild detergents (0.5-1% digitonin or n-dodecyl β-D-maltoside) while preserving native protein complexes, then separate by BN-PAGE and perform Western blotting with QCR7-2 antibody. Alternatively, use the antibody for co-immunoprecipitation studies to isolate intact Complex III and identify interacting partners by mass spectrometry. This approach can be particularly informative when comparing complex assembly under different stress conditions or in genetic mutants. Additionally, the antibody can be used in pulse-chase experiments to track the incorporation rate of newly synthesized QCR7-2 into the mature complex, providing insights into assembly dynamics.
Non-specific binding is a frequent challenge when working with QCR7-2 antibody. One primary cause is insufficient blocking, which can be addressed by extending blocking time to 2 hours or overnight and testing alternative blocking agents such as 5% BSA, casein, or commercial blockers. Another common issue is excessive antibody concentration; perform careful titration experiments starting from 1:500 to 1:5000 to determine optimal concentration that maximizes specific signal while minimizing background . Cross-reactivity with QCR7-1 (due to sequence homology) may occur; pre-absorb the antibody with recombinant QCR7-1 protein if available, or include QCR7-1 knockout controls. Inappropriate buffer conditions can also contribute to non-specific binding; optimize by adjusting salt concentration (150-500 mM NaCl) and detergent levels (0.05-0.3% Tween-20). Finally, ensure complete protein denaturation for Western blots and use freshly prepared samples to prevent degradation products that may result in spurious bands.
When confronted with weak or absent signals using QCR7-2 antibody, researchers should systematically evaluate several aspects of their experimental protocol. First, ensure efficient extraction of mitochondrial proteins through specialized isolation procedures, as cytosolic extracts may contain insufficient target protein. If signal remains weak, increase protein loading (30-50 μg per lane) and verify transfer efficiency using reversible staining methods like Ponceau S. Antibody concentration may need adjustment; try using a more concentrated primary antibody solution (1:500 instead of 1:2000) and extend incubation time to overnight at 4°C . Consider switching to a more sensitive detection system such as enhanced chemiluminescence (ECL) Plus or Super Signal. For challenging samples, PVDF membranes often provide better protein retention than nitrocellulose. Finally, confirm QCR7-2 expression in your experimental system, as expression levels may vary across tissues, developmental stages, or stress conditions.
Batch-to-batch variability in antibody performance presents significant challenges for experimental reproducibility. To mitigate this issue, implement a validation protocol for each new antibody lot, comparing it with previously validated lots using consistent positive control samples (e.g., Arabidopsis mitochondrial preparations known to express QCR7-2). Document key performance metrics including signal intensity, background levels, and detection threshold for each batch. When transitioning to a new lot, perform side-by-side experiments with both old and new antibody preparations using identical samples and conditions. Consider preparing a large batch of positive control samples that can be aliquoted and stored long-term for standardized comparisons across antibody lots. Maintain detailed records of antibody performance linked to lot numbers, supplier information, and receipt dates. Finally, when critical experiments are planned, acquire sufficient antibody from a single lot to complete the entire experimental series, minimizing variability.
QCR7-2 antibody offers multiple methodological approaches for investigating mitochondrial dysfunction during plant stress responses. First, use Western blotting to quantify changes in QCR7-2 protein levels across various stress conditions (drought, salinity, temperature extremes), normalizing to mitochondrial loading controls like VDAC. Second, employ blue native PAGE followed by immunoblotting to assess stress-induced alterations in Complex III assembly and stability. Third, use the antibody for immunoprecipitation followed by mass spectrometry to identify stress-specific post-translational modifications that may regulate QCR7-2 function. Fourth, perform co-immunoprecipitation studies under control and stress conditions to detect changes in protein-protein interactions that might impact respiratory chain function. Fifth, combine these biochemical approaches with physiological measurements of mitochondrial function (oxygen consumption, membrane potential, ROS production) to correlate molecular changes with functional outcomes. This multi-faceted approach can reveal how QCR7-2 and Complex III respond to environmental challenges and contribute to plant stress adaptation.
Comparative studies reveal fascinating parallels between plant QCR7-2 and its fungal orthologs, providing insights into the evolutionary conservation of mitochondrial functions. In Candida albicans, QCR7 knockout strains exhibit significantly reduced virulence and impaired biofilm formation . These mutants also show defects in mitochondrial function and altered utilization of alternative carbon sources such as GlcNAc, lactic acid, and amino acids . Similarly, in Saccharomyces cerevisiae, QCR7 is an essential component of the mitochondrial respiratory chain . These findings suggest evolutionary conservation of QCR7's role in respiratory complex assembly and mitochondrial function across diverse eukaryotes. To leverage these parallels methodologically, researchers could perform heterologous complementation studies, expressing plant QCR7-2 in fungal QCR7 knockout strains to assess functional conservation. Additionally, comparative structural analysis of Complex III organization across species could reveal conserved versus divergent aspects of QCR7 integration and function, providing insights into evolutionary adaptation of mitochondrial respiratory complexes.
QCR7-2 antibody provides multiple methodological avenues for investigating mitochondrial quality control mechanisms. Researchers can monitor QCR7-2 protein turnover rates under various stress conditions by combining cycloheximide chase assays with Western blotting. This approach can reveal how mitochondrial complexes are regulated during stress responses. To study mitophagy (selective degradation of mitochondria), dual immunofluorescence with QCR7-2 antibody and autophagy markers can visualize the engulfment of defective mitochondria. For investigating the unfolded protein response in mitochondria (UPRmt), researchers can monitor QCR7-2 levels in conjunction with known UPRmt markers following exposure to mitochondrial stressors. Additionally, the antibody can be used in pulse-chase experiments to track the fate of newly synthesized versus existing QCR7-2 protein during normal turnover or stress conditions. These approaches collectively provide insights into how mitochondrial respiratory complexes are maintained, repaired, or eliminated to preserve mitochondrial function and cellular homeostasis.
Integrating QCR7-2 antibody into single-cell analysis presents exciting opportunities for understanding mitochondrial heterogeneity at unprecedented resolution. For implementation, researchers can adapt the antibody for use in imaging flow cytometry by optimizing fixation, permeabilization, and staining protocols specifically for plant protoplasts or isolated cells. This approach allows simultaneous quantification of QCR7-2 levels, mitochondrial content, and other parameters in thousands of individual cells. For tissue-level analysis with single-cell resolution, combine QCR7-2 immunostaining with plant tissue clearing methods (like ClearSee) followed by confocal microscopy. To achieve subcellular detail, optimize QCR7-2 antibody labeling for super-resolution microscopy techniques (STED, STORM) to visualize Complex III distribution within individual mitochondria across different cell types. Additionally, develop computational image analysis pipelines specifically designed to segment individual cells within tissues and quantify QCR7-2 signals at the single-cell level, accounting for variations in cell size, shape, and mitochondrial content. These approaches together enable examination of cell-to-cell variability in mitochondrial composition and function within intact plant tissues.
QCR7-2 antibody holds significant potential for evolutionary studies of plant mitochondrial function through several methodological approaches. First, researchers can systematically test cross-reactivity of the antibody with mitochondrial extracts from diverse plant species, from mosses to angiosperms, to establish conservation patterns of the recognized epitope. Second, comparative Western blotting across species can reveal differences in protein size, abundance, and post-translational modifications that may reflect evolutionary adaptations. Third, the antibody can be used for immunoprecipitation studies across species to compare Complex III composition and interacting partners, potentially revealing evolutionary changes in complex organization. Fourth, researchers can compare QCR7-2 characteristics in closely related species adapted to different environments (drought-tolerant vs. mesic, high-altitude vs. lowland) to identify potential adaptive modifications in mitochondrial function. Finally, in plant hybrid species or allopolyploids, the antibody can help investigate which parental version of QCR7-2 is predominantly expressed and incorporated into functional complexes, providing insights into mitochondrial genome evolution and regulation.
QCR7-2 antibody offers several methodological approaches for investigating the intricate coordination between mitochondria and chloroplasts in plants. Researchers can perform dual immunolocalization studies using QCR7-2 antibody alongside chloroplast markers to analyze physical associations between these organelles under different physiological conditions. Co-immunoprecipitation with QCR7-2 antibody followed by mass spectrometry can identify potential protein interactors that might function in mitochondria-chloroplast communication. To study metabolic integration, combine QCR7-2 protein analysis with metabolomic approaches to correlate Complex III status with metabolite exchange between organelles. For examining the impact of photosynthetic activity on respiratory chain components, monitor QCR7-2 expression and Complex III assembly across different light regimes and photosynthetic mutants. Additionally, the antibody can be used to compare mitochondrial responses in green versus non-green tissues of the same plant, providing insights into how respiratory complexes adapt to different metabolic contexts. These approaches together can illuminate how plants coordinate these two energetic organelles to optimize cellular energy metabolism under changing environmental conditions.